腎素(REN)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)
ELISA Kit for Renin (REN)
angiotensinogenase
- 編號USEA889Hu
 - 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
 - 實(shí)驗(yàn)方法雙抗夾心
 - 反應(yīng)時長3h
 - 檢測范圍31.2-2,000pg/mL
 - 靈敏度最小可檢測劑量小于等于12.2pg/mL.
 - 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
 - 下載 英文說明書 中文說明書
 - 規(guī)格 48T96T 96T*5 96T*10 96T*100
 - 價格 ¥ 1008 ¥ 1440 ¥ 6480 ¥ 12240 ¥ 100800
 - 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
                        本試劑盒用于檢測腎素(REN),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
                        由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
                    
回收率
分別于定值血清及血漿樣本中加入一定量的腎素(REN)(加標(biāo)樣品),重復(fù)測定并計算其均值,回收率為測定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) | 
| serum(n=5) | 80-88 | 84 | 
| EDTA plasma(n=5) | 81-101 | 97 | 
| heparin plasma(n=5) | 95-103 | 101 | 
精密度
                    精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100 
                    批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進(jìn)行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
                    批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進(jìn)行定量測定,每個樣本使用同一試劑盒重復(fù)測定8次,分別計算不同濃度樣本的平均值及SD值。
                    批內(nèi)差: CV<10% 
                    批間差: CV<12% 
                
線性
在定值血清及血漿樣本內(nèi)加入適量的腎素(REN),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中腎素(REN)含量的測定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 79-90% | 80-104% | 86-102% | 85-98% | 
| EDTA plasma(n=5) | 93-105% | 85-101% | 90-98% | 87-94% | 
| heparin plasma(n=5) | 90-103% | 90-97% | 99-105% | 98-105% | 
穩(wěn)定性
                    經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
                    為減小外部因素對試劑盒破壞前后檢測值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。
                
實(shí)驗(yàn)流程
                    1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
                            2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時;
                            3. 吸棄,加檢測溶液A100µL,37°C孵育1小時;
                            4. 洗板3次;
                            5. 加檢測溶液B100µL,37°C孵育30分鐘;
                            6. 洗板5次;
                            7. 加TMB底物90µL,37°C孵育10-20分鐘;
                            8. 加終止液50µL,立即450nm讀數(shù)。
                
實(shí)驗(yàn)原理
將腎素(REN)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的腎素(REN)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的腎素(REN)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍(lán)色,并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的腎素(REN)呈正相關(guān)。用酶標(biāo)儀在450nm波長下測定吸光度(O.D.值),計算樣品濃度。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| UAPA889Hu61 | 腎素(REN)活性蛋白 | Cell?culture;?Activity?Assays. | 
| UEPA889Hu61 | 腎素(REN)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA889Hu01 | 腎素(REN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAA889Hu01 | 腎素(REN)多克隆抗體 | WB; ICC/IF | 
| UMAA889Hu23 | 腎素(REN)單克隆抗體 | WB; IHC; ICC; IP. | 
| UMAA889Hu21 | 腎素(REN)單克隆抗體 | WB; IHC; ICC; IP. | 
| UMAA889Hu25 | 腎素(REN)單克隆抗體 | WB; IHC; ICC; IP. | 
| UMAA889Hu24 | 腎素(REN)單克隆抗體 | WB; IHC; ICC; IP. | 
| UMAA889Hu22 | 腎素(REN)單克隆抗體 | WB | 
| USEA889Hu | 腎素(REN)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| USCA889Hu | 腎素(REN)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| ULMA889Hu | 腎素(REN)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Hypertension | Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat [PubMed: 21045727] | 
| The Journal of Physiology | Recombinant human erythropoietin in humans down-regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate [Physoc: 194241] | 
| The Journal of Physiology | Erythropoietin down‐regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate in humans [PubMed: 20724370] | 
| Pathobiology | Anti-Angiotensin and Hypoglycemic Treatments Suppress Liver Metastasis of Colon Cancer Cells [Karger: 000330169] | 
| Journal of Cardiovascular Pharmacology | The Angiotensin Receptor Blocker, Azilsartan Medoxomil (TAK-491), Suppresses Vascular Wall Expression of Plasminogen Activator Inhibitor Type-I Protein Potentially Facilitating the Stabilization of Atherosclerotic Plaques [LWW: 08000] | 
| Kidney International | Multiple and large simple renal cysts are associated with prehypertension and hypertension. [Pubmed: 23389415] | 
| Human Physiology | Estimation of the parameters of the renin-angiotensin-aldosterone system, water-electrolyte metabolism, and endothelial function in newborns of women with chronic hypertension [Springer:Source] | 
| Journal of Pharmacological Sciences | Organ-Specific Activation of the Gastric Branch of the Efferent Vagus Nerve by Ghrelin in Urethane-Anesthetized Rats [Pubmed:24366191] | 
| Liver International | VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis [Pubmed:24750552] | 
| Gynecological Endocrinology | Immunological and hemostasiological disorders in women with ovarian hyperstimulation syndrome [Pubmed:25200828] | 
| Oxidative Medicine and Cellular Longevity | Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice [Pubmed:27200147] | 
| PLoS One | Ablation of Potassium-Chloride Cotransporter Type 3 (Kcc3) in Mouse Causes Multiple Cardiovascular Defects and Isosmotic Polyuria [Pubmed:27166674] | 
| PLOS?ONE | Reduced?Expression?of the?Extracellular?Calcium-Sensing?Receptor?(CaSR) Is?Associated?withActivation?of the?Renin-Angiotensin?System?(RAS) to Promote Vascular Remodeling in the Pathogenesis of Essential Hypertension. [pubmed:27391973] | 
| Heart Lung Circ. | Efficacy and Safety of Renal Sympathetic Denervation on Dogs with Pressure Overload-Induced Heart Failure. [pubmed:27555054] | 
| European Journal of Pharmaceutical Sciences | Sacubitril/valsartan (LCZ696) Significantly Reduces Aldosterone and Increases cGMP Circulating Levels in a Canine Model of RAAS Activation [Doi: 10.1101/435560] | 
| Nutrition | Gut Dysbiosis Contribute to High Fructose Induced Salt Sensitive Hypertension In Sprague-Dawley Rats [] | 
| ACTA PHARMACOLOGICA SINICA | The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice [33303990] | 
| Hypertens Res | Association of Ang-(1¨C7) and des-Arg 9 BK as new biomarkers of obesity and cardiometabolic risk factors in adolescents [33568792] | 
| Phosphorylation of ?21-integrin in juxtaglomerular cells helps control blood pressure during the progression of diabetic nephropathy [] | |
| Bedeutung des intrarenalen Renin-Angiotensin-Systems f¨1r die Entwicklung der chronischen Nierenkrankheit [] | 

                    
                    
                                    
